Provascor Pharmaceuticals | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,895 results for “Provascor Pharmaceuticals”

UConn Stroke Drug Advances Towards Clinical Trials with NIH Grant

HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)

Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio

MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets

ARIAD Pharmaceuticals Accelerates Ponatinib to Market

OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger

Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK

Lipigon Pharmaceuticals Appoints Johan Liwing as New CEO

Actinium Pharmaceuticals' Actimab-A Receives Orphan Designation in the EU for AML Treatment

Avadel's LUMRYZ Maintains Market Exclusivity as Court Upholds FDA Approval

Page 1 of 461